IPP Bureau
Shilpa Biologicals' PartnerPower promises real-time transparency in biologics development
By IPP Bureau - June 23, 2026
New digital platform provides global sponsors with live visibility into R&D, process development and GMP manufacturing operations, enhancing collaboration and decision-making
KIMS Hospitals launches RENOVA Oncology Institute in Bengaluru
By IPP Bureau - June 23, 2026
KIMS RENOVA Oncology Institute, in association with the Samrohana Cancer Foundation, announced the “134 Free Screening Camp Pledge”,
Teva submits FDA application for experimental Tourette syndrome treatment ecopipam
By IPP Bureau - June 23, 2026
The filing is backed by positive Phase 3 results recently published in JAMA Neurology
FDA advisory panel backs Moderna flu vaccine candidate for older adults
By IPP Bureau - June 23, 2026
The backing comes as influenza remains a persistent public health burden
FDA clears 131 drugs as global pharma approval momentum rebounds in 2025
By IPP Bureau - June 23, 2026
After a volatile decade in which approvals swung sharply from year to year, 2025’s total pushed past long-term norms, exceeding the 10-year average
Roche’s Lunsumio VELO–Polivy combo moves closer to FDA decision after strong lymphoma trial results
By IPP Bureau - June 23, 2026
The safety profile of the Lunsumio and Polivy combination was consistent with the known profiles of the individual study medicines
WuXi Biologics wins fourth EMA certification for Suzhou Biosafety Center
By IPP Bureau - June 23, 2026
Clearing 19 biologics for Europe market
ZEISS and Envision Health Technologies team up to push VR-based glaucoma testing forward
By IPP Bureau - June 23, 2026
The move comes as demand rises for wider access to glaucoma screening and more flexible clinical workflows
HCG launches breast Cancer Care Clinic in Bengaluru
By IPP Bureau - June 23, 2026
About 250+ women riders participate in the awareness ride where free breast screening camp were conducted
Parexel biotech incubator to connect early-stage innovation with clinical development expertise
By IPP Bureau - June 23, 2026
The incubator anchored at the company's global headquarters in Raleighla launches alongside an inaugural partnership with Cape Fear BioCapital, a Durham-based seed-stage venture capital firm
Lonza reports CHF 3.03 billion in sales amid divestment of Capsules & Health Ingredients unit
By IPP Bureau - June 23, 2026
As per the company’s Restated H1 2025 Financials, its continuing business delivered CORE EBITDA of CHF 922 million, representing a margin of 30.4%
QMS Medical targets Rs. 500 crore revenue by FY29
By IPP Bureau - June 23, 2026
The company reported consolidated revenue of Rs. 172.9 crore and EBITDA of Rs 25.9 crore in FY26
India achieves landmark milestone of 5 lakh organ donation pledges
By IPP Bureau - June 23, 2026
As per union government, growing public participation reflects rising awareness and collective commitment towards advancing organ and tissue donation
KIMS Hospitals Bengaluru launches KIMS RENOVA Oncology Institute
By IPP Bureau - June 23, 2026
Advanced comprehensive oncology centre was inaugurated by the legendary former Indian cricketer VVS Laxman
BioMed X and Biogen launch global neuroimmunology research challenge
By IPP Bureau - June 23, 2026
Initiative seeks innovative experimental and computational approaches to uncover neural circuits regulating immune function and identify novel therapeutic targets
